Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative Treatment for Cervical Intra-epithelial Neoplasia: a Randomised Controlled Trial - The NOVEL Trial
Latest Information Update: 30 Sep 2024
At a glance
- Drugs V 503 (Primary)
- Indications Cervical intraepithelial neoplasia; Human papillomavirus infections
- Focus Therapeutic Use
- Acronyms NOVEL
- 20 Sep 2024 Planned End Date changed from 31 Jul 2023 to 31 Aug 2025.
- 20 Sep 2024 Planned primary completion date changed from 31 Jul 2023 to 31 Aug 2025.
- 20 Sep 2024 Status changed to active, no longer recruiting.